Sular Related Published Studies
Well-designed clinical trials related to Sular (Nisoldipine)
Comparative efficacy and safety of nisoldipine extended-release (ER) and amlodipine (CESNA-III study) in African American patients with hypertension. [2003.09]
Long term effects of nisoldipine on the progression of coronary atherosclerosis and the occurrence of clinical events: the NICOLE study. [2003.08]
Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris. [2003.02.01]
Usefulness of Nisoldipine for prevention of restenosis after percutaneous transluminal coronary angioplasty (results of the NICOLE study). NIsoldipine in COronary artery disease in LEuven. [2001.01.01]
Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy. [2000.12]
A comparison of nisoldipine ER and amlodipine for the treatment of mild to moderate hypertension. [2000.10]
Protective effect of nisoldipine on myocardial ischemia during coronary bypass surgery. [1999.10]
Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate. [1999.08]
The effect of ketoconazole on the pharmacokinetics, pharmacodynamics and safety of nisoldipine. [1999.03]
Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy. [1999.03]
Antihypertensive monotherapy with nisoldipine CC is superior to enalapril in black patients with severe hypertension. [1999.02]
Left ventricular remodelling in post-myocardial infarction patients with left ventricular ejection fraction 40-50% vs 25-39%. Influence of nisoldipine treatment? An echocardiographic substudy from the DEFIANT II study. [1999]
Effects of nisoldipine and lisinopril on microvascular dysfunction in hypertensive Type I diabetes patients with nephropathy. [1998.12]
Comparison between cilnidipine and nisoldipine with respect to effects on blood pressure and heart rate in hypertensive patients. [1998.09]
A comparison of nisoldipine coat-core and felodipine in the treatment of mild-to-moderate hypertension. [1998.06]
The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. [1998.03.05]
Nisoldipine CC and lisinopril alone or in combination for treatment of mild to moderate systemic hypertension. Canadian Nisoldipine CC Hypertension Trial Group. [1997.09]
Pharmacokinetics of the controlled-release nisoldipine coat-core tablet formulation. [1997.08]
Comparative efficacy and tolerability of nisoldipine coat core and hydrochlorothiazide in mild-to-moderate hypertension. [1997.07]
Recovery of left ventricular function following early reperfusion in acute myocardial infarction: a potential role for the calcium antagonist nisoldipine. [1997.03]
Effects of nisoldipine and/or enalapril on left ventricular function and exercise capacity in patients with recent anterior myocardial infarction and mild cardiac dysfunction. [1997.03]
Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators. [1997.03]
Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment. [1997.03]
Antianginal and anti-ischemic efficacy of nisoldipine in stable angina pectoris: a randomized, double-blind, placebo-controlled trial. [1996.11]
A study to investigate the comparative efficacy and tolerability of nisoldipine coat-core and atenolol in the treatment of mild to moderate hypertension. [1996.10]
Nisoldipine versus isosorbide dinitrate in coronary heart disease: results of a double-masked study. [1996.05]
Comparison of once daily and twice daily nisoldipine as monotherapy in essential hypertension. [1996.04]
Antianginal and antiischemic efficacy of monotherapy extended-release nisoldipine (Coat Core) in chronic stable angina. [1995.08]
Comparison of efficacy of nisoldipine, metoprolol, and isosorbide dinitrate in patients with stable exertional angina: a randomized, cross-over, placebo-controlled study. [1995.02]
A comparison of once daily versus twice daily nisoldipine as monotherapy in patients over 65 years of age. [1994.10]
Effects of nisoldipine therapy on myocardial perfusion and neuro-hormonal status in patients with severe ischaemic left ventricular dysfunction. [1994.07]
Antianginal and anti-ischemic efficacy of immediate-release nisoldipine in chronic stable angina pectoris. [1994.06.15]
Pharmacokinetic and pharmacodynamic interactions during multiple-dose administration of nisoldipine and propranolol. [1994.06]
The DEFIANT study of left ventricular function and exercise performance after acute myocardial infarction. Doppler Flow and Echocardiology in Functional Cardiac Insufficiency: Assessment of Nisoldipine Therapy Study Group. [1994.05]
[Comparison of nisoldipine and diltiazem in the treatment of effort angina pectoris] [1994.02]
[Effect of nisoldipine and diltiazem on systolic and diastolic function of the left ventricle in patients with coronary heart disease] [1994.01]
Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics. [1993.12]
A comparison of the acute haemodynamic effects of nisoldipine and nifedipine during treatment with atenolol in patients with coronary artery disease. [1993.10]
[Dose-response relationship of nisoldipine in patients with stable angina pectoris and stress-induced myocardial ischemia] [1993.09]
Left ventricular systolic and diastolic function, and exercise capacity six to eight weeks after acute myocardial infarction. The DEFIANT Study Group. Doppler Flow and Echocardiography in Functional Cardiac Insufficiency: Assessment of Nisoldipine Therapy. [1993.07.15]
A comparison of nisoldipine and nifedipine, in combination with atenolol, in the management of myocardial ischaemia. [1993.04]
Comparison of nisoldipine and nifedipine as additional treatment in hypertension inadequately controlled by atenolol. [1993.02]
[Comparison of the cardiodepressive effects of nifedipine, isradipine, nisoldipine and felodipine in patients with coronary heart disease] [1993.01]
Effect of nisoldipine on ambulatory blood pressure under 24-hour noninvasive monitoring. [1992.10]
Analysis of the mechanisms underlying the changes in left ventricular filling dynamics during oral nisoldipine therapy in patients with anterior myocardial infarction. [1992.07]
Partial attenuation of the cardiovascular responses to tracheal intubation with oral nisoldipine. [1992.07]
Multiple dose pharmacokinetics of four different doses of nisoldipine in hypertensive patients. [1992.06]
Hemodynamic effects of nisoldipine, a highly specific calcium antagonist, in patients with acute myocardial infarction. [1992.02]
Effects of prolonged nisoldipine administration on the "hibernating" myocardium. [1992]
Effects of calcium antagonists in patients with coronary disease and heart failure: left ventricular function following nisoldipine measured by radionuclide ventriculography. [1992]
Specific coronary hemodynamic effects of nisoldipine and other vasoactive drugs. [1992]
[A comparative study of nisoldipine and alpha-methyldopa in aged patients with isolated systolic hypertension] [1991.12]
Nifedipine and nisoldipine in hypertensive diabetics. [1991.12]
The effects of nisoldipine on the total ischaemic burden: the results of the ROCKET study. [1991.12]
Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris. [1991.12]
Usefulness of oral nisoldipine for stable angina pectoris. The Nisoldipine Multicenter Angina Study Group. [1991.10.15]
Effects of nisoldipine on systolic and diastolic function in postinfarction patients with reduced left ventricular function: a randomized, double-blind, placebo controlled study. [1991.09]
The interactions between nisoldipine and two beta-adrenoceptor antagonists--atenolol and propranolol. [1991.09]
Hemodynamic changes after subselective intracoronary administration of nisoldipine in humans. [1991.09]
[Nisoldipine in stable angina pectoris. Efficacy and tolerance in comparison with diltiazem] [1991.05.10]
Improvement of silent myocardial ischaemia and reduction of plasma fibrinogen during nisoldipine therapy in occult coronary arterial disease. [1991.04]
Effects of nisoldipine on myocardial ischemia during exercise and during daily activity. [1991.03.15]
Effect of the calcium antagonists nifedipine, nitrendipine, nimodipine and nisoldipine on oesophageal motility in man. [1991]
Effects of nisoldipine on stress-induced changes in haemodynamics and plasma catecholamines in normotensives and hypertensives. [1990.12]
[Effect of the calcium antagonist nisoldipine on coronary circulation and myocardial ischemia in temporary coronary occlusion] [1990.10]
Acute and long-term haemodynamic and neurohumoral response to nisoldipine vs captopril in patients with heart failure: a randomized double-blind study. [1990.08]
Acute effects of nisoldipine, propranolol, and their combination in patients with chronic stable angina: a double-blind, randomized, cross-over, placebo-controlled study. [1990.08]
Efficacy and tolerance of nisoldipine VS propranolol in patients with essential hypertension. [1990.07]
[Nisoldipine in the therapy of stable exercise angina: evaluation of its efficacy in ergometric tests compared with propranolol] [1990.06]
Nisoldipine tablets once daily versus nifedipine capsules three times daily in patients with stable effort angina pectoris pretreated with atenolol. [1990.04]
Comparative haemodynamic effects of intravenous nisoldipine and hydralazine in congestive heart failure. [1990.03]
Calcium channel blocker nisoldipine in chronic renal failure. [1990]
Effect of nisoldipine (BAY k 5552) on methacholine-induced bronchoconstriction in patients with nonspecific bronchial hyperreactivity. [1989.12]
The efficacy and tolerability of nifedipine (NIF) and nisoldipine (NIS) both alone and combined with a beta-blocker in patients with essential hypertension: a multicenter, parallel-group study. [1989.11]
Comparison of nisoldipine and atenolol in the treatment of essential hypertension. [1989.03]
Use of exercise Doppler for non-invasive haemodynamic optimization of dose and identification of poor responders to an oral anti-anginal agent. A double-blind dose-finding study of nisoldipine. [1988.10]
The effect of nisoldipine on whole blood platelet aggregation in patients with Raynaud's phenomenon. [1988.06]
Rapid development of tolerance to the antihypertensive effect of nisoldipine. [1988.03]
The calcium channel blocker nisoldipine delays progression of chronic renal failure in humans (preliminary communication). [1988.01]
Pharmacokinetic and pharmacodynamic interactions between nisoldipine and propranolol. [1988.01]
Effect of the calcium channel blocker nisoldipine on the progression of chronic renal failure in man. [1988]
The pharmacology of nisoldipine. [1987.12]
Monotherapy with the calcium channel antagonist nisoldipine for systemic hypertension and comparison with diuretic drugs. [1987.09.15]
Nisoldipine in primary Raynaud's phenomenon. [1987]
Well-designed clinical trials possibly related to Sular (Nisoldipine)
Serum phosphorus and cardiovascular mortality in type 2 diabetes. [2009.04]
Mobilization of putative high-proliferative-potential endothelial colony-forming cells during antihypertensive treatment in patients with essential hypertension. [2007.04]
Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension. [2006.09]
Effects of a mononitrate, a beta1-blocker and a dihydropyridine calcium channel blocker on cardiovascular responsiveness to passive orthostasis: a placebo-controlled double-blind study in normotensive volunteers. [2005]
Differential effects of antihypertensive agents on electrocardiographic voltage: results from the Appropriate Blood Pressure Control in Diabetes (ABCD) trial. [2003.06]
Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. [2003.02.11]
Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. [2002.03]
Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes. [2000.07]
Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. [2000.04]
Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial. [1998.11.12]
Long-term therapy with an ACE inhibitor, temocapril, reduces microalbuminuria in essential hypertension. [1998.06]
Quantitation of left ventricular volumes and ejection fraction in post-infarction patients from biplane and single plane two-dimensional echocardiograms. A prospective longitudinal study of 371 patients. [1998.05]
Interaction between grapefruit juice and diazepam in humans. [1998.01]
New evidence on the prevention of cardiovascular events in hypertensive patients with type 2 diabetes. [1998]
What, if anything, is controversial about calcium antagonists? [1996.12]
Appropriate Blood Pressure Control in NIDDM (ABCD) Trial. [1996.12]
Baseline characteristics of participants in the Appropriate Blood Pressure Control in Diabetes trial. [1996.06]
|